Document:

<PAGE>   1
                                                                  EXHIBIT 10.110

                                   AGREEMENT

         THIS AGREEMENT ("Agreement"), dated as of the ___day of September,
2000, is by and between Vision Twenty-One, Inc., a Florida corporation ("Vision
21"), Optometric Associates of Florida, P.A., a Florida professional
association (the "Practice"), Optometric Consultants of Florida, P.A., a
Florida professional association ("OCF"), TNG Management, Inc., a Florida
corporation ("TNG"), and Theodore N. Gillette (the "Shareholder").

                                   RECITALS

         WHEREAS, Vision 21 acquired certain of the Assets (as defined in
Section 1(a) hereof) of the Practice pursuant to the following agreements: (i)
Asset Purchase Agreement dated as of December 1, 1996 between Vision 21, Dr.
Gillette & Associates, #6965, P.A. (now known as Optometric Associates of
Florida, P.A.) and the Shareholder (the "Original Practice Transaction
Agreement"); and (ii) Agreement and Plan of Reorganization dated as of May 1,
1998 between Vision 21, the Practice, Richard A. Sills, P.A. and Richard A.
Sills, O.D.;

         WHEREAS, in connection with the Original Practice Transaction
Agreement, Vision 21 entered into a business management relationship with the
Practice pursuant to a Business Management Agreement dated as of December 1,
1996 (as amended from time to time, hereinafter referred to as the "BMA");

         WHEREAS, Vision 21 acquired certain of the Assets from OCF pursuant to
that certain Asset Purchase Agreement dated as of April 1, 1998 (the "Original
OCF Transaction Agreement") by and among Vision 21, OCF and Mitchell F.
Goldstein, O.D., the then current shareholder of OCF;

         WHEREAS, in connection with the Original OCF Transaction Agreement,
Vision 21 entered into a business management relationship with the Practice
pursuant to a Business Management Agreement dated April 1, 1998 (the "OCF
BMA");

         WHEREAS, TNG desires to acquire certain assets of Vision 21 used in
connection with the management of optometric practices and TNG desires to enter
into an agreement with the Practice to provide certain over-head and management
services related to optometry, and the parties agree that TNG and the Practice
may only enter into such an agreement upon the termination or transfer of the
BMA;

         WHEREAS, the Shareholder is the sole shareholder of TNG; and

         WHEREAS, in furtherance of Vision 21's plan to exit the optometry
practice management business, Vision 21 desires to transfer certain rights
under the BMA to TNG, to transfer to TNG certain assets relating to the
Practice and OCF and to assign certain obligations relating to the Practice and
OCF upon the terms and conditions set forth herein.

<PAGE>   2

         NOW THEREFORE, in consideration of the mutual covenants set forth
herein, and intending to be legally bound hereby, the parties hereto hereby
agree as follows:

         Section 1.        Basic Transaction.

         (a)      Purchase and Sale of Assets. Effective as of the Effective
Date (as defined in Section 1(e) hereof), Vision 21 agrees to sell, transfer,
convey and deliver to TNG on the terms and subject to the conditions set forth
herein, and TNG agrees to purchase from Vision 21, the assets set forth on
Schedule 1(a) hereto (the "Assets"), which such Assets shall be free and clear
of any liens or encumbrances except as otherwise set forth herein. The Assets
shall not include: (i) the CRIS System software and related computer hardware,
(ii) the Marco COS 1000 at the office premises used by the Practice in Palm
Harbor, (iii) any cash collected by Vision 21 in accordance with the BMA
through the Effective Date, and (iv) any cash, cash equivalents or accounts
receivable owned by the Practice or OCF or rights assigned to Vision 21 under
the BMA or the OCF BMA to collect the Practice's or OCF's accounts receivable
through the Effective Date. All of the Practice's cash, cash equivalents and
cash accounts receivable outstanding as of the Effective Date shall be assigned
by the Practice to Vision 21 at the Closing pursuant to a Working Capital
Assignment and Sale Agreement (the "Working Capital Assignment") in a form
acceptable to the parties. All of OCF's cash, cash equivalents and cash
accounts receivable outstanding as of the Effective Date relating to or arising
from any of the office locations set forth on Schedule 1(b) (the "Office
Premises") shall be assigned by OCF to Vision 21 at the Closing pursuant to a
Working Capital Assignment in a form acceptable to the parties. The Practice
and the Shareholder shall cooperate with Vision 21 in the collection of the
Practice's and OCF's accounts receivable outstanding as of the Effective Date,
and any such accounts receivable collected by the Practice or the Shareholder
shall be forwarded to Vision 21 within three (3) days of the Practice's and/or
the Shareholder's receipt thereof.

         (b)      Assumption of Liabilities. Effective as of the Effective
Date, Vision 21 shall assign to TNG, and TNG shall assume and become
responsible for (i) each lease obligation for equipment currently utilized in
the Office Premises, (ii) except for the equipment leased by Principal
Management Corporation to Vision 21 which will be subleased by Vision 21 to TNG
pursuant to a separate Equipment Sublease Agreement, each contract or other
obligation entered into by Vision 21, the Practice or OCF for services or
equipment used in connection with the optometry practice at any of the Office
Premises, (iii) all obligations with respect to the Employees (as defined in
Section 1(f) hereof) for paid time off ("PTO") accrued prior to the expiration
of the Transition Period (as defined in Section 1(e) hereof) and all
obligations with respect to the Employees arising from and after the Effective
Date, (iv) all other obligations and liabilities relating to the Practice
arising from and after the Effective Date, and (v) all other obligations and
liabilities relating to OCF which relate to any of the Office Premises arising
from and after the Effective Date. TNG, the Practice and OCF shall use their
best efforts to cause the landlord for each real property location and each
lessor of equipment to release Vision 21 from any further obligations or
liabilities under the real property or personal property leases, which best
efforts shall include, without limitation, the personal guarantee of the
Shareholder if requested by the landlords or the lessors. At Closing, TNG shall
reimburse Vision 21 in an amount equal to the aggregate of any security
deposits held by the real property or equipment lessors and not returned to
Vision 21 at the time of TNG's assumption of the lease obligations. TNG, the
Practice, OCF and the Shareholder on the one hand and Vision 21 on the other
hand, shall provide all

                                       2
<PAGE>   3

information to the other party necessary to set forth with specificity the
assumed liabilities on a schedule to the Assignment and Assumption Agreement to
be delivered at Closing in accordance with Section 1(h) hereof.

         (c)      Business Management Agreement. Effective as of the Effective
Date, Vision 21 shall assign to TNG all of Vision 21's right, title and
interest in and to the BMA. The parties acknowledge that the BMA may be
assigned by Vision 21 only with the written consent of the Practice and by
execution of this Agreement the Practice hereby consents to Vision 21's
assignment of the BMA to TNG. Effective as of the Effective Date, neither
Vision 21 nor the Practice or the Shareholder shall have any further
obligations or liabilities to the other under the BMA, except for those
indemnification obligations to Vision 21 on the part of the Practice and the
Shareholder regarding malpractice claims which shall survive Vision 21's
transfer of its rights in and to the BMA to TNG.

         (d)      Consideration. The consideration to be given by TNG to Vision
21 in connection with the purchase of the Assets (the "Consideration"), shall
be Four Hundred Twelve Thousand One Hundred Seventeen and No/100 Dollars
($412,117) which shall be paid by TNG at Closing pursuant to a promissory note
in substantially the form attached hereto and made a part hereof as Exhibit A
(the "Note"). Each of the Shareholder and his spouse, Raena Gillette, shall
personally guarantee payment of the Note pursuant to guaranty agreements in
substantially the form of the guaranty agreements attached to the Note (the
"Guaranty Agreement(s)").

         (e)      Effective Date. The transactions contemplated by this
Agreement shall close (the "Closing") when this Agreement and all closing
deliveries set forth in Section 1(j) hereof are fully executed and/or delivered
by the parties. The effective date of the Closing of the transactions
contemplated by this Agreement shall be 11:59 p.m. on August 25, 2000 (the
"Effective Date").

         (f)      Employees. Effective as of the Effective Date, each of the
employees of Vision 21 set forth on Schedule 1(f) hereto which Vision 21
employed to provide services at the Office Premises (the "Employees") shall be
deemed terminated as employees of Vision 21 and hired as employees of TNG. From
and after the Effective Date, TNG shall be responsible for paying salaries,
providing fringe benefits and for withholding, as required by law, any sums for
income tax, unemployment insurance, social security, or other withholding
required by applicable law or governmental requirement. Vision 21 shall remain
liable for salary and required withholding that accrued prior to the Effective
Date and for fringe benefits, other than PTO, that accrued prior to the
Effective Date. Effective as of the Effective Date, TNG shall maintain
appropriate workers' compensation coverage for all of the Employees and other
personnel employed by TNG and professional and comprehensive general liability
insurance covering TNG and all of the Employees and all of its other personnel.
Vision 21 shall satisfy any salary or fringe benefit obligations, other than
PTO, accrued prior to the expiration of the Transition Period and TNG shall
obtain from each of the Employees a release (collectively, the "Employee
Releases") of Vision 21 from all of such liabilities and from any and all other
liabilities of any kind or nature related to Vision 21's employment of the
Employees.

         Notwithstanding the preceding paragraph, the parties acknowledge and
confirm that TNG has requested that Vision 21 continue to employ the Employees
for such period after the Effective Date as TNG may request, ending no later
than the end of the calendar month which includes the Closing (the

                                       3
<PAGE>   4

"Transition Period"), and lease their services to TNG on an at cost basis.
During the Transition Period, Vision 21 shall pay the salaries for these
Employees and provide them with fringe benefits, including coverage under
Vision 21's group health plan. Vision 21 will be responsible for all payroll
tax withholding required by law, including FICA, FUTA and all income or wage
tax withholding required by any applicable federal, state or local law, or any
other applicable payroll taxes with respect to compensation payable to the
Employees for services performed during the Transition Period. Vision 21 will
maintain appropriate workers compensation coverage of the Employees during such
Transition Period. TNG will pay to Vision 21 an amount equal to all
compensation payments to be made to the Employees and all applicable insurance
premiums or payroll taxes paid or payable by Vision 21 with respect to the
Employees (collectively, the "Employee Expense Reimbursement") for the period
from the Effective Date to the last day of the Transition Period. Vision 21
shall provide to TNG the Employee Expense Reimbursement amount prior to the
date such amount is required to be paid (the "Due Date"), and TNG shall pay
such amount in cash to Vision 21 not less than two (2) business days prior to
the Due Date.

         (g)      Termination of Noncompetition Covenant. Upon Closing, the
non-competition covenants between and among the parties set forth in the
Original Practice Transaction Agreement, the BMA, the Employment Agreement and
any related agreements shall be terminated and shall be of no further force or
effect.

         (h)      Termination of Employment Agreement; Resignation. The
Employment Agreement dated October 1, 1996 between Vision 21 and the
Shareholder shall be deemed terminated as of the Effective Date and of no
further force or effect and Shareholder hereby discharges any outstanding
amounts payable thereunder. Simultaneously with the Closing, Shareholder shall
resign as the Chief Executive Officer of Vision 21. Shareholder shall resign as
a member of the Board of Directors of Vision 21 at the next meeting of the
Board of Directors.

         (i)      Participation on Managed Care Provider Panels. Subsequent to
the Closing, if the Optometrists employed or contracted by the Practice meet
the credentialing and other participatory requirements of each managed vision
care plan, Vision 21 and/or Block Vision, Inc., a wholly-owned subsidiary of
Vision 21 ("Block"), shall ensure that such optometrists are included on the
provider panels for all third party plans administered by Vision 21 and/or
Block covering any part of the Tampa Bay market for the professional services
component of the covered benefits. With respect to each of the optometrists,
the amount of reimbursement and the process for determining eligibility shall
be consistent with past practices. The maximum time frame for payment shall be
within State of Florida guidelines, provided however that payment will not be
made by Block or Vision 21 until receipt by Block or Vision 21 of reimbursement
from those vision care plans that compensate Block or Vision 21 on a fee for
service basis. Managed care provider agreements shall be executed by the
parties within thirty (30) days of closing reflecting the above understandings.

                                       4
<PAGE>   5

         (j)      Deliveries at Closing.

                  (1)      At the Closing, Vision 21 shall deliver the
                           following documents:

                           (a)      Assignment and Bill of Sale from Vision 21
                                    to TNG with a representation and warranty
                                    as to title and ownership (the "Assignment
                                    and Bill of Sale");
                           (b)      Equipment sublease agreement contemplated
                                    by Section 1(b);
                           (c)      Assignment and Assumption agreement in a
                                    form acceptable to TNG;
                           (d)      Security Agreement securing full and timely
                                    payment of the Note and UCC-1 financing
                                    statements to evidence such security
                                    interest (the "Security Agreement");
                           (e)      Such other instruments of sale, transfer,
                                    conveyance and assignment as the Practice
                                    or OCF may reasonably request; and
                           (f)      Such other documents as may be necessary to
                                    effectuate the transactions contemplated
                                    hereby.

                  (2)      At the Closing, the Practice, OCF and the
                           Shareholder shall deliver, or cause to be delivered,
                           the following:

                           (a)      Consent to assignment of BMA from Vision 21
                                    to TNG;
                           (b)      Guaranty of the Note from the Shareholder;
                           (c)      Guaranty  of the Note from Raena Gillette;
                           (d)      Subleases (the "Subleases") entered into by
                                    the Practice for each of the Office
                                    Premises in forms acceptable to Vision 21,
                                    which forms shall contain a release by the
                                    sublessor of such Subleases of Vision 21
                                    from any and all liabilities or obligations
                                    under any prior sublease arrangements
                                    between such sublessor and Vision 21
                                    relating to the Office Premises;
                           (e)      Consents of landlords for each of the
                                    Office Premises consenting to the
                                    Practice's entry into the Subleases and
                                    acknowledging that Vision 21 has no further
                                    liability with respect to the Office
                                    Premises;
                           (f)      Working Capital Assignment from the
                                    Practice contemplated by Section 1(a)
                                    hereof;
                           (g)      Working Capital Assignment from
                                    OCF contemplated by Section 1(a) hereof;
                                    and
                           (h)      Such other documents as may be
                                    necessary to effectuate the transactions
                                    contemplated hereby.

                  (3)      At the Closing, TNG shall deliver the following:

                           (a)      Note;
                           (b)      Assignment and Bill of Sale;
                           (c)      Assignment and Assumption of leases for
                                    each of the Office Premises in form
                                    acceptable to Vision 21;

                                       5
<PAGE>   6

                           (d)      Security Agreement and UCC-1 financing
                                    statements;
                           (e)      Evidence of payment of State of Florida
                                    documentary taxes;
                           (f)      Assignment and Assumption Agreement in form
                                    acceptable to Vision 21;
                           (g)      Employee Releases in form acceptable to
                                    Vision 21;
                           (h)      Expense Reimbursement contemplated by
                                    Section 1(k) hereof and the reimbursement
                                    for security deposits contemplated by
                                    Section 1(b) hereof;
                           (i)      Equipment Sublease Agreement contemplated
                                    by Section 1(b) hereof;
                           (j)      Such other instruments of assumption as
                                    Vision 21 may reasonably request; and
                           (k)      Such other documents as may be necessary to
                                    effectuate the transactions contemplated
                                    hereby.

                  (k)      Expense Reimbursement. TNG shall reimburse Vision 21
for expenses incurred by Vision 21 in providing corporate functions requested
by TNG relating to payroll, benefits, management information systems support,
RSS services and accounting services from and after the Effective Date.

                  (l)      Interim Period. Vision 21 shall not be liable for
any liabilities, obligations or expenses incurred or arising during the period
from and after the Effective Date until the Closing (the "Interim Period") with
respect to the Practice or any of the Office Premises. Vision 21 shall have no
obligation to collect the Practice's or OCF's accounts receivable arising
during the Interim Period. If any such accounts receivable arising during or
after the Interim Period are remitted to Vision 21, Vision 21 shall forward
such accounts receivable to TNG within three (3) days of Vision 21's receipt
thereof.

         Section 2.        Representations and Warranties.

         (a)      Representations and Warranties of Vision 21. Vision 21 hereby
represents and warrants to the Practice, OCF, TNG and the Shareholder that the
following are true and correct as of the Closing:

                  (i)      Vision 21 is duly authorized to execute, deliver and
perform this Agreement and any other agreement contemplated hereby, and to
consummate the transactions contemplated hereby and the Agreement and each
other agreement contemplated hereby are the legal, valid and binding
obligations of Vision 21, enforceable against it in accordance with their
respective terms.

                  (ii)     The information provided by Vision 21 with respect
to the assumed liabilities to be set forth in the Assignment and Assumption
Agreement to be delivered at Closing will be true and correct in all respects.

                  (iii)    The Assets shall be transferred to TNG at Closing
free and clear of all liens and encumbrances whatsoever, except for the liens
of the Banks (defined below) which will be released concurrently with the
Closing.

                                       6
<PAGE>   7

         (b)      Representations and Warranties of the Practice, OCF and the
Shareholder. The Practice, OCF and the Shareholder jointly and severally hereby
represent and warrant to Vision 21 that the following are true and correct as
of the Closing:

                  (i)      The Practice and OCF are duly authorized to execute,
deliver and perform this Agreement and any other agreement or instrument
contemplated hereby, and to consummate the transactions contemplated hereby,
and the Agreement and each other agreement contemplated hereby are the legal,
valid and binding obligations of the Practice, OCF and the Shareholder,
enforceable against each such party in accordance with their respective terms.

                  (ii)     Except as set forth on Schedule 2(b)(ii) hereto, (a)
there are no prepaid expenses, unbilled accounts receivable, unbilled services
or similar items, (b) neither the Shareholder nor any individual acting at the
direction of the Shareholder has deposited or otherwise disposed of any revenue
collected by or on behalf of the Practice since the effective date of the BMA
other than in accordance with the BMA, (c) neither the Shareholder nor any
individual acting at the direction of the Shareholder has deposited or
otherwise disposed of any revenue collected by or on behalf of the Practice
since the effective date of the OCF BMA other than in accordance with the OCF
BMA, and (d) all ledger entries and other information provided by or on behalf
of the Practice or OCF to Vision 21 with respect to any revenue collected by or
on behalf of the Practice or OCF since the effective date of the BMA (in the
case of the Practice) or the OCF BMA (in the case of OCF), including receipts
for Professional Eye Care Services (as defined in the BMA and the OCF BMA),
have been complete and accurate in all respects.

                  (iii)    Except as set forth on Schedule 2(b)(iii) hereto,
none of the Practice, OCF or the Shareholder have incurred any commitments,
obligations or liabilities on behalf of or in the name of the Practice or OCF
since the effective date of the BMA or the OCF BMA.

                  (iv)     The information provided by the Shareholder, OCF and
the Practice with respect to the assumed liabilities to be set forth in the
Assignment and Assumption Agreement to be delivered at Closing will be true and
correct in all respects.

         (c)      Representations and Warranties of TNG. TNG hereby represents
and warrants that:

                  (i)      TNG is duly authorized to execute, deliver and
perform its obligations under this Agreement, the Note and any other agreement
contemplated hereby to be executed and delivered by TNG, and to consummate the
transactions contemplated hereby, and this Agreement, the Note and each other
agreement contemplated hereby to be executed and delivered by TNG are the
legal, valid and binding obligations of TNG, enforceable against it in
accordance with their respective terms.

                           TNG, the Practice, OCF and the Shareholder
acknowledge that the approval of the transactions contemplated herein by Vision
21's Board of Directors and the banks which are a party to Vision 21's Credit
Agreement, as amended, will be in reliance upon the representations and
warranties of TNG, the Practice and the Shareholder set forth herein.

                                       7
<PAGE>   8

         Section 3.        Confidentiality and Nondisparagement Covenants.

         (a)      Confidentiality Covenant. Except as needed to facilitate this
Agreement, no party hereto shall, directly or indirectly, use for any purpose,
or disclose to any third party, any information of any other party hereto
(whether written or oral), including any business management or economic
studies, patient lists, proprietary forms, proprietary business or management
methods, marketing data, fee schedules, or trade secrets, including the terms
and provisions of this Agreement and any transaction or document executed by
the parties pursuant to this Agreement. Notwithstanding the foregoing, a party
hereto (the "Disclosing Party") may disclose any information that (i) is or
becomes generally available to and known by the public or the ophthalmic,
optometric or optical community (other than as a result of an unpermitted
disclosure directly or indirectly by the Disclosing Party or his affiliates,
advisors, or representatives); (ii) is or becomes available to the Disclosing
Party on a nonconfidential basis from a source other than another party hereto
or its affiliates, advisors or representatives, provided that such source is
not and was not bound by a confidentiality agreement with or other obligation
of secrecy to the party to which the confidential information relates or his or
its affiliates, advisors or representatives of which the Disclosing Party has
knowledge; (iii) has already been or is hereafter independently acquired or
developed by the Disclosing Party without violating any confidentiality
agreement with or other obligation of secrecy to the party to which the
confidential information relates or his or its affiliates, advisors or
representatives; or (iv) the Disclosing Party is required by law to disclose.
Without limiting the other possible remedies to the party to which the
confidential information relates for the breach of this covenant, the parties
hereto agree that injunctive or other equitable relief shall be available to
enforce this covenant, such relief to be without the necessity of posting a
bond, cash or otherwise.

         (b)      Nondisparagement Covenant. Each of the parties hereto
covenant and agree that they shall not at any time make or publish any
negative, critical or disparaging comments or statements, whether written or
oral, about any of the parties hereto, or their respective officers, directors
or employees.

         Section 4.        Vision 21 Stock Options.

         (a)      Shareholder Stock Options. Effective as of the Effective
Date, except for those Stock Option Agreements relating to the Shareholder's
services as an employee, director, consultant or advisor for Vision 21, if any,
all Stock Option Agreements, if any, between Vision 21 and the Shareholder
shall be deemed to be terminated except that any stock options which are fully
vested as of the Effective Date may be exercised (subject to forfeiture upon
any breach by the Shareholder of the restrictive covenants set forth in
Sections 3 and 13 of this Agreement) within ninety (90) days after the
Effective Date, in accordance with the terms of the applicable Stock Option
Agreement.

         (b)      Stock Options of Employees and Non-Shareholder Professionals.
Effective as of the Effective Date, all Stock Option Agreements, if any,
between Vision 21 and any Employees or any professional employees of the
Practice other than the Shareholders shall be deemed to be terminated except
that any stock options which are fully vested as of the Effective Date may be
exercised within ninety days after the Effective Date, in accordance with the
terms of the applicable Stock Option Agreement.

                                       8
<PAGE>   9

         Section 5.        Indemnification.

         (a)      Indemnification by Practice, OCF and Shareholder. The
Practice, OCF and the Shareholder, jointly and severally, shall defend,
indemnify and hold Vision 21 and TNG and their respective officers, directors,
employees and agents harmless from and shall pay all losses, damages, fees,
expenses or costs (including reasonable attorney's fees) incurred by them based
upon any claim arising out of any breach by the Practice, OCF or the
Shareholder of any of their obligations, agreements, representations or
warranties herein.

         (b)      Indemnification by Vision 21. Vision 21 shall defend,
indemnify and hold the Shareholder, the Practice, OCF and TNG, and their
respective officers, directors, employees and agents harmless from and shall
pay all losses, damages, fees, expenses or costs (including reasonable
attorney's fees) incurred by them based upon any claim arising out of any
breach by Vision 21 of any of its obligations, agreements, representations or
warranties herein.

         (c)      Indemnification by TNG. TNG shall defend, indemnify and hold
the Shareholder, the Practice, OCF and Vision 21, and their respective
officers, directors, employees and agents harmless from and shall pay all
losses, damages, fees, expenses or costs (including reasonable attorney's fees)
incurred by them based upon any claim arising out of any breach by TNG of any
of its obligations, agreements, representations or warranties herein.

         Section 6.        Mutual Releases.  Effective upon the Closing:

         (a)      The Shareholder and the Practice, and their respective
successors and assigns do hereby release and forever discharge Vision 21 and
its officers, directors, shareholders, partners, agents, employees, affiliated
entities, affiliated professionals, successors and assigns, of and from any and
all claims, demands, liabilities, costs, expenses, actions and causes of action
of whatsoever kind or nature, whether in law or equity, from the beginning of
time to the date of the Closing, which the Shareholder or the Practice may have
or claim to have, whether known to them or not, against Vision 21, except for
the obligations under this Agreement, and the obligations arising under any
managed care provider agreement between the Shareholder or the Practice and any
Vision 21 affiliated entity. Except as specifically set forth in this Section
6, this release is a general release and the parties intend and agree that it
shall be interpreted, construed and enforced as such.

         (b)      Vision 21 and its successors and assigns do hereby release
and forever discharge each of the Shareholder and the Practice, and their
respective officers, directors, shareholders, partners, agents, employees,
affiliated entities, affiliated professionals, successors and assigns, of and
from any and all claims, demands, liabilities, costs, expenses, actions and
causes of action of whatsoever kind or nature, whether in law or equity, from
the beginning of time to the date of the Closing, which Vision 21 may have or
claim to have, whether known to them or not, against the Shareholder or the
Practice, except for (i) those indemnification obligations on the part of the
Practice and the Shareholder regarding malpractice claims which shall survive
termination or assignment of the BMA, (ii) the obligations under this
Agreement, (iii) the obligations arising under any managed care provider
agreement between the Shareholder or the Practice and any Vision 21 affiliated
entity, and

                                       9
<PAGE>   10

(iv) the obligations of Theodore N. Gillette in his capacity as an officer or a
member of the Board of Directors of Vision 21.

         This Section 6 shall be of no force or effect until Closing.

         Section 7.        No Assignment of Claims; Advice of Counsel. Each
party hereto warrants and represents that no part of any of the above asserted
or assertable claims have been assigned or transferred, and that he or it has
full, exclusive and unencumbered right, title and interest in and to them. Each
party further warrants and represents that he or it has carefully read and
fully understands this Agreement (and the release provisions contained herein)
and has signed it voluntarily after being fully advised by his or its legal
counsel.

         Section 8.        No Prior Breach. By executing this Agreement, the
parties hereto are not acknowledging a breach of any agreement between the
parties and affirm that the parties have mutually agreed not to continue the
previously established business relationships referred to herein, except as
otherwise provided herein.

         Section 9.        Remedies. The parties agree that a breach of this
Agreement by any party shall result in immediate and irreparable harm to the
other parties hereto. Accordingly, the parties agree that the non-defaulting
parties may seek and obtain injunctive or other equitable relief as against the
defaulting party hereunder, without posting bond or other security, in addition
to any other remedies available at law or in equity.

         Section 10.       Governing Law; Waiver of Jury Trial. This Agreement
shall be governed by the laws of the State of Florida without regard to such
state's rules concerning conflicts of laws. Any right to trial by jury with
respect to any claim or proceeding related to or arising out of this Agreement
is waived.

         Section 11.       Entire Agreement; Counterparts. This Agreement
reflects the entire agreement between the parties hereto with respect to the
subject matter hereof and no provision hereof may be modified or waived unless
such modification or waiver is in writing and is signed by all of the parties
hereto. This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute
one and the same agreement.

         Section 12.       Binding Effect. The provisions of this Agreement
shall be binding upon and inure to the benefit of the parties hereto.

         Section 13.       Confidentiality. Except as and to the extent
required by law, including, without limitation, any disclosures required under
federal and state securities and tax law, none of the parties hereto will, and
each will direct its or his officers, directors, employees, agents and
representatives not to, directly or indirectly, disclose or permit the
disclosure of the terms of this Agreement without the prior written permission
of the other parties hereto.

         Section 14.       Attorneys' Fees. In the event of any litigation
arising out of or relating to this Agreement, the prevailing party shall be
entitled to recover all costs and reasonable attorneys' fees

                                      10
<PAGE>   11

incurred, including, but not limited to, costs and fees incurred in any
investigations, trials, bankruptcies and appeals.

         Section 15.       Expenses; Documentary Taxes. Each of the parties
shall be responsible for and will pay its own expenses incurred in connection
with the negotiation of the transactions contemplated hereunder. TNG shall be
responsible for and shall submit evidence of its payment of State of Florida
documentary taxes relating to the Note at Closing.

         Section 16.       DISCLAIMER OF WARRANTIES. The assets shall be
transferred to TNG "as is, where is" with no warranties or representations
other than title and ownership. Vision 21 disclaims all other warranties,
express or implied, in connection with the assets, including but not limited to
the implied warranties of merchantibility and fitness for a particular purpose.

         Section 17.       Further Assurances. From and after the Closing, upon
the reasonable request of any party, the other parties shall execute and
deliver such instruments, documents and other writings as may be reasonably
necessary to effectuate the intent and purpose of this Agreement.

         Section 18.       Full Access. After the Closing, TNG, the Practice,
OCF and the Shareholder shall provide Vision 21 with access, upon prior
reasonable written request specifying the need therefor, during regular
business hours, to the books of account and records of the Practice for the
period from the date of the Original Practice Transaction Agreement and the
Original OCF Transaction Agreement until the Effective Date, and Vision 21 and
its representatives shall have the right to make copies of such books and
records.

         Section 19.       Cooperation. Each of the parties hereto will
cooperate with the other in all respects, and each of the parties will execute
and deliver to the other parties hereto such other instruments and documents
and take such other actions as may be reasonably requested from time to time by
any other party hereto as necessary to carry out, evidence and confirm the
intended purposes of this Agreement. Such cooperation shall include, without
limitation, assistance to Vision 21 by TNG, the Shareholder and the Practice
as necessary in conjunction with any audits of Vision 21's financial
statements, including the timely completion of information requests or other
inquiries as required by Vision 21 or its auditors.

         Section 20.       Defined Terms. All capitalized terms not otherwise
defined in this Agreement shall have the meaning ascribed to such terms in the
BMA.

         Section 21.       Acknowledgment. Vision 21, TNG, the Practice and the
Shareholder each acknowledge their consent to the legal representation of
Vision 21 by Shumaker, Loop & Kendrick, LLP in connection with this Agreement
and the transactions contemplated hereby, and hereby waive any conflict of
interest that may result from such representation. TNG, the Practice and the
Shareholder each further acknowledge that they have retained their own
independent legal counsel to represent them in connection with this Agreement.

                                      11
<PAGE>   12

         IN WITNESS WHEREOF, the parties hereto have executed this Agreement as
of the date first above written.

VISION TWENTY-ONE, INC.                  OPTOMETRIC ASSOCIATES OF
                                         FLORIDA, P.A.

By:      /s/ Bruce Maller                By:  /s/ Theodore N. Gillette
   -----------------------------------      -----------------------------------
   Bruce Maller, Chairman of the Board      Theodore N. Gillette, its President

TNG MANAGEMENT, INC.                     OPTOMETRIC CONSULTANTS OF
                                         FLORIDA, P.A.

By:     /s/ Theodore N. Gillette         By:  /s/ Theodore N. Gillette
   -----------------------------------      -----------------------------------
   Theodore N. Gillette, President          Theodore N. Gillette, its President

                                              /s/ Theodore N. Gillette
                                            -----------------------------------
                                            Theodore N. Gillette, individually

                                      12
<PAGE>   13

                                 Schedule 1(a)
                                     Assets

1.       All furniture, fixtures and equipment used in the operation of the
         Practice and located at each of the office premises listed on Schedule
         1(b) (the "office premises");

2.       All inventory of supplies used in the operation of the Practice or OCF
         and located at any of the Office Premises;

3.       All files, books and records used at the Office Premises;

4.       All telephone numbers used at the Office Premises;

5.       All leaseholds and leasehold improvements for the leased real property
         and all leaseholds for the leased equipment located at the Office
         Premises; and

6.       All trade names used by the Practice.

                                      13
<PAGE>   14

                                 Schedule 1(b)

                                Office Locations

<TABLE>
<CAPTION>
<S> <C>                                 <C>
1.  #6946 - Clearwater                  810 Missouri Avenue, Clearwater, Fl  33756
2.  #6947 - Tampa (E. Fowler)           2001 E. Fowler Avenue, Tampa, Fl  33612
3.  #6948 - St. Pete (Tyrone)           2143 Tyrone Blvd., St. Petersburg, Fl  33710
4.  #6949 - Palm Harbor                 30715 U.S.19 N., Palm Harbor, Fl  34684
5.  #6951 - Sarasota                    891 Tamiami Trail, Sarasota, Fl  34236
6.  #6954 - St. Pete (4th St.)          3301 4th Street N., St. Petersburg, Fl  33704
7.  #6957 - Tampa (S. Dale Mabry)       700 S. Dale Mabry, Tampa, Fl  33609
8.  #6965 - Port Richey                 9644 Scenic Drive, Port Richey, Fl  34668
9.  #6978 - Seminole                    11212 Park Blvd., Seminole, Fl  33772
10. #6980 - Tampa (N. Dale Mabry)       14901 N.Dale Mabry, Tampa, Fl  33618
11. #9374 - Citrus Park                 8150 Citrus Park Town Center, Tampa, Fl  33625
12. #6972 - Fort Myers                  12320 S. Cleveland Avenue, Fort Myers, Fl  33907
13. #9370 - Port Charlotte              18500 Veterans Blvd. #4, Port Charlotte, Fl  33954
</TABLE>

                                      14
<PAGE>   15

                                 Schedule 1(f)

                               Practice Employees

                            See list annexed hereto.

                                   15
<PAGE>   16

                               Schedule 2(b)(ii)

    Prepaid Expenses; Unbilled Accounts Receivable; Unbilled Services; etc.

                                      None

                                      16
<PAGE>   17

                               Schedule 2(b)(iii)

                  Commitments; Obligations; Liabilities; etc.

                                      None

                                      17
<PAGE>   18

                                   EXHIBIT A

                                PROMISSORY NOTE

                                  See attached

                                      18<PAGE>   1
                                                                  EXHIBIT 10.111

                              SETTLEMENT AGREEMENT

         THIS SETTLEMENT AGREEMENT ("Agreement"), dated as of the 14th day of
September, 2000, is by and among Vision Twenty-One, Inc., a Florida corporation
("Vision 21"), Minnesota Eye Consultants, P.A., a Minnesota professional
association (the "Practice"), Richard L. Lindstrom, M.D., David R. Hardten, M.D.
and Thomas W. Samuelson, M.D. (collectively, the "Shareholders"), and Laser
Vision Centers, Inc. ("LVCI").

                                 R E C I T A L S

         WHEREAS, Vision 21 acquired the Assets (as defined in Section 1(e)
hereof) pursuant to the following agreements: (i) Asset Purchase Agreement,
effective December 1, 1996, among Vision 21, the Practice (then known as
Lindstrom, Samuelson & Hardten Ophthalmology Associates, P.A.) and the
Shareholders (the "MEC Transaction Agreement"), (ii) Asset Purchase Agreement,
effective October 28, 1997, among Vision 21, First Eye Care Center, Inc., Jerome
D. Poland, M.D., Ltd. and Jerome Poland, M.D., (iii) Asset Purchase Agreement,
effective August 1, 1998, among Vision 21, the Practice, New Prague Vision
Clinics, P.A., Tim Goldsmith, O.D. and Wendy Goldsmith, O.D., (iv) Agreement and
Plan of Reorganization, effective December 1, 1996, among Vision 21, Cambridge
Eye Clinic - John W. Lahr, Optometrist, P.A. and John W. Lahr, O.D., (v)
Agreement and Plan of Reorganization, effective December 1, 1996, among EE
Optical Lab, Inc., John W. Lahr, O.D. and Mary Jo Lahr, (vi) Agreement and Plan
of Reorganization, effective February 1, 1998, among Vision 21, the Practice
(then known as Lindstrom, Samuelson & Hardten Ophthalmology Associates, P.A.),
Dr. Byron A. Teska, P.A. and Byron A. Teska, M.D., (the "Teska Transaction
Agreement"), and (vii) Agreement and Plan of Reorganization, effective October
1, 1998, among Vision 21, Jerome D. Poland, M.D., Ltd. and Jerome D. Poland,
M.D.; and

         WHEREAS, in connection with the MEC Transaction Agreement and the Teska
Transaction Agreement, Vision 21 entered into a business management relationship
with the Practice pursuant to Business Management Agreements, as thereafter
amended (collectively, the "BMA"). Under the BMA, Vision 21 was appointed by the
Practice as its sole and exclusive agent for the management of the business
functions and business affairs of the Practice; and

         WHEREAS, pursuant to the BMA, the Practice is entitled under certain
circumstances to terminate the BMA and to reacquire the Assets (as defined in
Section 1(e)) for a price similar to net book value using as consideration for
such purchase stock of Vision 21 issued in connection with the MEC Transaction
Agreement valued at the greater of the then current price or the price as of the
original MEC Transaction Agreement; and

         WHEREAS, the BMA also permitted the Practice under certain
circumstances to terminate the BMA without reacquiring any assets and for no
cost; and

         WHEREAS, pursuant to the BMA, Vision 21 is entitled under certain
circumstances to terminate to BMA; and

                                       1
<PAGE>   2

         WHEREAS, on or about November 1999, certain disputes arose between
Vision 21 on the one hand and the Practice and the Shareholders on the other
hand regarding the parties' performance of their respective obligations under
the BMA and their rights upon default under the BMA to unwind the business
management relationship and terminate the BMA; and

         WHEREAS, the Practice asserted in late 1999 that Vision 21 had breached
its obligations under the BMA, among other things by failing to pay significant
amounts of income over to the Practice which were due to the Practice. As a
consequence, the Practice notified Vision 21 that effective as of November 30,
1999 it would not continue to perform as provided in the BMA. The Practice did
not at that time exercise any option to reacquire the Assets nor did it release
any other claims against Vision 21; and

         WHEREAS, on December 15, 1999, Vision 21, the Practice and the
Shareholders entered into a letter of understanding (the "Letter of
Understanding") which was effective November 30, 1999 (the "Effective Date") and
which set forth the principal terms upon which such parties proposed a
transaction (the "Unwind") whereby they would unwind their business management
relationship and ultimately terminate the BMA on the closing of the Unwind; the
parties agreed that they would not perform their respective obligations under
the BMA beginning with the Effective Date, but continued to discuss options for
a go-forward relationship which might be memorialized in a Restated Business
Management Agreement and might involve Vision 21's provision of technical
services related to refractive surgery to the Practice, for consideration to be
agreed to by the parties; and

         WHEREAS, LVCI, MEC and the Shareholders desire to enter into an
agreement whereby LVCI provides laser access and other related services to MEC
in return for MEC's and the Shareholders' agreement to use LVCI exclusively for
such services and MEC and the Shareholders have advised LVCI that it may only
enter into such agreement upon the termination or transfer of the BMA; and

         WHEREAS, the closing of the Unwind has not yet occurred and thus, the
BMA is still in full force and effect, and since the date of the Letter of
Understanding, (i) Vision 21, the Practice and the Shareholders have resolved
their disputes and have determined the final terms pursuant to which the
Practice and Vision 21 will release the other of their respective obligations
under the BMA and the Practice shall assume certain equipment and real estate
lease obligations relating to the Practice, and (ii) Vision 21 and LVCI have
reached an agreement for Vision 21's transfer of its rights but excluding all
obligations and liabilities of Vision 21 under the BMA to LVCI; and

         WHEREAS, the parties now wish to memorialize their agreements with
respect to the subject matter hereof as set forth herein.

         NOW THEREFORE, in consideration of the mutual covenants set forth
herein, and intending to be legally bound hereby, the parties hereto hereby
agree as follows:

                                       2
<PAGE>   3

         Section 1.        Basic Transaction.

         (a)      Business Management Agreement. At the Closing, Vision 21 shall
assign to LVCI all of Vision 21's right, title and interest in and to the BMA
but excluding all past and future obligations and liabilities of Vision 21 under
the BMA. The parties acknowledge that the BMA may be assigned by Vision 21 only
with the written consent of the Practice and by execution of this Agreement the
Practice hereby consents to Vision 21's assignment of such interests under the
BMA to LVCI. The parties further acknowledge that, simultaneously with the
Closing, LVCI and the Practice shall either amend and restate the BMA or
terminate the same and enter into a new agreement setting forth the terms and
conditions of their business relationship. Effective as of the Effective Date,
neither Vision 21 nor the Practice or the Shareholders shall have any further
obligations or liabilities to the other under the BMA, except for those
indemnification obligations to Vision 21 on the part of the Practice and the
Shareholders regarding malpractice claims which shall survive Vision 21's
transfer of its rights in and to the BMA to LVCI.

         (b)      Consideration. In consideration of the assignment of Vision
 21's rights under the BMA described above, and the covenants and agreements of
the parties hereunder, LVCI shall pay to Vision 21 at the Closing, Two Million
One Hundred Ninety Thousand and 00/100 Dollars ($2,190,000), (the
"CONSIDERATION"), by wire transfer of immediately available funds to an account
designated by Vision 21.

         (c)      Payment of Certain Remaining Obligations. At the Closing,
Vision 21 shall pay (i) $40,000 to Jack Moore to fully settle and discharge Jack
Moore's claims regarding Minnesota Eye Care Associates; (ii) $13,333.33 to each
of Drs. Lindstrom, Hardten and Samuelson to fully settle and discharge their
claims regarding Minnesota Eye Care Associates; (iii) $15,000 to each of Drs.
Lindstrom, Samuelson and Hardten to fully settle and discharge any and all
claims relating to the Advanced Refractive Training Institute; and (iv) $65,000
to Richard L. Lindstrom, M.D. to fully settle and discharge any claims relating
to the Medical Advisory Agreement dated September 9, 1996 between Vision 21 and
Richard L. Lindstrom, M.D.

         (d)      Termination of Related Agreements. Upon Closing, the following
agreements shall be terminated and of no further force or effect and each
Shareholder hereby discharges any outstanding amounts payable thereunder and
agrees to deliver Jack Moore's discharge of same at Closing (i) the Medical
Advisory Agreement dated September 9, 1996 between Vision 21 and Richard L.
Lindstrom, M.D., and (ii) the Regional Services Agreements dated May 29, 1997
between Vision 21 and each of Richard L. Lindstrom, M.D., David R. Hardten,
M.D., Thomas W. Samuelson, M.D., and Jack Moore.

                                       3
<PAGE>   4

         (e)      Transfer of Assets. Effective as of the Effective Date (as
defined on page 2 hereof), Vision 21 shall transfer, convey and deliver to the
Practice and the Shareholders or their designees on the terms and subject to the
conditions set forth herein, the assets as set forth on Schedule 1(e) hereto
(together, all of the assets identified on Schedule 1(e) shall be referred to
herein as the "Assets"), which such Assets shall be free and clear of any liens
or encumbrances except as otherwise set forth herein.

         (f)      Assumption of Liabilities. Effective as of the Effective Date,
Vision 21 shall assign to the Practice, and the Practice shall assume and become
responsible for (i) the outstanding accounts payable or other obligations
incurred by or on behalf of Vision 21 or the Practice by the Shareholders or
personnel working at the Practice (including, without limitation, personnel
employed by Vision 21) relating to services, supplies and equipment for the
Practice; (ii) each of the real property leases entered into by Vision 21 for
the office premises used by the Practice; (iii) each lease obligation for
equipment currently utilized in the office premises of the Practice, except for
the equipment leased by Principal Management Corporation ("PMC") to Vision 21
under Schedules 3 through 6 of the Master Lease between PMC and Vision 21 which
will be subleased by Vision 21 to the Practice pursuant to a separate sublease
agreement; (iv) each contract or other obligation entered into by Vision 21 or
the Practice for services or equipment used in connection with the Practice; (v)
all obligations with respect to the Employees (as defined in Section 1(h)
hereof) for paid time off ("PTO") accrued prior to the expiration of the
Transition Period (as defined in Section 1(h) hereof) and all obligations with
respect to the Employees arising from and after the Effective Date; and (vi) all
other obligations and liabilities relating to the Practice arising from and
after the Effective Date. The Practice shall use its best efforts to cause the
landlord for each real property location and each lessor of equipment to release
Vision 21 from any further obligations or liabilities under the real property or
personal property leases. At Closing, the Practice shall reimburse Vision 21 in
an amount equal to the aggregate of any security deposits held by the real
property or equipment lessors and not returned to Vision 21 at the time of the
Practice's assumption of the lease obligations. The Practice and the
Shareholders on the one hand and Vision 21 on the other hand, shall provide all
information to the other party necessary to set forth with specificity the
assumed liabilities on a schedule to the assumption agreement to be delivered at
Closing in accordance with Section 1(i) hereof.

         (g)      Closing. The transactions contemplated by this Agreement shall
close (the "Closing") when this Agreement and all closing deliveries set forth
in Section 1(i) hereof are fully executed and/or delivered by the parties. The
Closing shall be continent upon the parties' approval of closing documents
described in Section 1(i) below. Execution by each of the parties thereto shall
evidence such parties approval of the documents so executed. The effective date
of the transactions contemplated by this Agreement shall be the Effective Date.

         (h)      Employees. The parties acknowledge and confirm that effective
as of the last day of the Transition Period (as defined below), each of the
employees of Vision 21 set forth on Schedule 1(h) hereto which Vision 21
employed to provide services for the Practice (the "Employees") were terminated
as employees of Vision 21 and hired as employees of the Practice. The parties
acknowledge that from and after the Effective Date, the Practice has reimbursed
Vision 21 for salaries, fringe benefits and for withholding, income tax,
unemployment insurance, social

                                       4
<PAGE>   5

security, or other withholding. Vision 21 paid for salary and required
withholding that accrued prior to the last day of the Transition Period and for
fringe benefits, other than PTO, that accrued prior to the last day of the
Transition Period. Effective as of the last day of the Transition Period, the
Practice has maintained appropriate workers' compensation coverage for all of
the Employees and other personnel employed by the Practice and professional and
comprehensive general liability insurance covering the Practice and all of the
Employees and all of its other personnel. Vision 21 represents and warrants that
it has satisfied any salary, tax, withholding, or fringe benefit obligations,
other than PTO, accrued prior to the last day of the Transition Period. The
Practice shall fully cooperate with Vision 21 in obtaining releases from each of
the Employees of Vision 21 from all liabilities of any kind or nature related to
Vision 21's employment of Employees.

                  Notwithstanding the preceding paragraph, the Practice and
Vision 21 acknowledge and confirm that the Practice requested that Vision 21
continue to employ the Employees for the period commencing on the Effective Date
and ending on January 29, 2000 (the "Transition Period"), and lease the services
of the Employees to the Practice on an at cost basis. During the Transition
Period, Vision 21 paid the salaries for these Employees and provided them with
fringe benefits, including coverage under Vision 21's group health plan through
January 31, 2000. Vision 21 was responsible for all payroll tax withholding
required by law, including FICA, FUTA and all income or wage tax withholding
required by an applicable federal, state or local law, or any other applicable
payroll taxes with respect to compensation payable to the Employees for services
performed during the Transition Period. Vision 21 maintained appropriate workers
compensation coverage of the Employees during such Transition Period.

         (i)      Deliveries at Closing.

                  (1)      At the Closing, Vision 21 shall deliver the following
                           documents:

                           (a)      Assignments and Bills of Sale for the Assets
                                    from Vision 21 to the Practice and the
                                    Shareholders or their designees with a
                                    representation and warranty as to title and
                                    ownership;
                           (b)      Duly executed assignments of leases from
                                    Vision 21 to the Practice for each of the
                                    Practice's Offices and for the Practice's
                                    leased equipment;
                           (c)      Such other instruments of sale, transfer,
                                    conveyance and assignment from Vision 21 as
                                    the Practice may reasonably request;
                           (d)      The equipment sublease agreement between
                                    Vision 21 and the Practice contemplated by
                                    Section 1(f) hereof;
                           (e)      The assignment from Vision 21 to LVCI
                                    contemplated by Section 1(a) hereof; and
                           (f)      Such other documents as may be necessary to
                                    effectuate the transactions contemplated
                                    hereby.

                  (2)      At the Closing, the Practice and the Shareholders
                           shall deliver the following:

                                       5
<PAGE>   6

                           (a)      Assumption agreement contemplated by Section
                                    1(f) in form acceptable to Vision 21;
                           (b)      Such other instruments of assumption as
                                    Vision 21 may reasonably request;
                           (c)      The Lease Expense Reimbursement, if any,
                                    contemplated by Section 1(j) hereof and the
                                    reimbursement for security deposits
                                    contemplated by Section 1(f) hereof.;
                           (d)      The equipment sublease agreement between
                                    Vision 21 and the Practice contemplated by
                                    Section 1(f) hereof;
                           (e)      The discharge from Jack Moore contemplated
                                    by Section 1(d) hereof;
                           (f)      The agreement with LVCI regarding the BMA
                                    contemplated by Section 1(a) hereof; and
                           (g)      Such other documents as may be necessary to
                                    effectuate the transactions contemplated
                                    hereby.

                  (3)      At the Closing, LVCI shall deliver the following:

                           (a)      The Consideration.
                           (b)      The agreement with MEC regarding the BMA
                                    contemplated by Section 1(a) hereof; and
                           (c)      Such other documents as may be necessary to
                                    effectuate the transactions contemplated
                                    hereby.

                  (j)      Lease Expense Reimbursement. At the Closing, the
Practice shall reimburse Vision 21 for all equipment lease expenses set forth on
Schedule 1(j) not previously reimbursed by the Practice (the "Lease Expense
Reimbursement").

         Section 2.        Mutual Releases. Effective upon the Closing:

         (a)      The Shareholders and the Practice, and their respective
successors and assigns do hereby release and forever discharge Vision 21 and its
officers, directors, shareholders, partners, agents, employees, affiliated
entities, affiliated professionals, successors and assigns, of and from any and
all claims, demands, liabilities, costs, expenses, actions and causes of action
of whatsoever kind or nature, whether in law or equity, from the beginning of
time to the date of this Agreement, which the Shareholders or the Practice may
have or claim to have, whether known to them or not, against Vision 21, except
for the obligations under this Agreement, and the obligations arising under any
managed care provider agreement between the Shareholders or the Practice and any
Vision 21 affiliated entity. This release is a general release and the parties
intend and agree that it shall be interpreted, construed and enforced as such.

         (b)      Vision 21 and its successors and assigns do hereby release and
forever discharge each of the Shareholders and the Practice, and their
respective officers, directors, shareholders, partners, agents, employees,
affiliated entities, affiliated professionals, successors and assigns, of and
from any and all claims, demands, liabilities, costs, expenses, actions and
causes of action of whatsoever kind or nature, whether in law or equity, from
the beginning of time to the date of this

                                       6
<PAGE>   7

Agreement, which Vision 21 may have or claim to have, whether known to them or
not, against the Shareholders or the Practice, except for: (i) those
indemnification obligations on the part of the Practice and the Shareholders
regarding malpractice claims which shall survive Vision 21's assignment of the
BMA to LVCI; (ii) the obligations under this Agreement; and (iii) the
obligations arising under any managed care provider agreement between the
Shareholders or the Practice and any Vision 21 affiliated entity.

         Each of Vision 21, the Practice and the Shareholders warrants and
represents to the other parties that no part of any of the above asserted or
assertable claims have been assigned or transferred, and that each has full,
exclusive and unencumbered right, title and interest in and to such claims. Each
of Vision 21, the Practice and the Shareholders further warrants and represents
to the other parties that it has carefully read and fully understands this
Agreement (and the release provisions contained herein) and has signed it
voluntarily after being fully advised by its legal counsel.

         This Section 2 shall be of no force or effect until Closing.

         Section 3.        No Prior Breach. By executing this Agreement, neither
Vision 21, nor the Practice, nor the Shareholders are acknowledging a breach of
any agreement among them and each affirms that it has mutually agreed not to
continue the previously established business relationships referred to herein
and each has agreed to settle its respective disputes as set forth herein.

         Section 4.        Representations and Warranties.

         (a)      Representations and Warranties of Vision 21. Vision 21 hereby
represents and warrants that:

                  (i) Vision 21 is duly authorized to execute, deliver and
perform its obligations under this Agreement and any other agreement
contemplated hereby to be executed and delivered by Vision 21, and to consummate
the transactions contemplated hereby, and this Agreement and each other
agreement contemplated hereby to be executed and delivered by Vision 21, are the
legal, valid and binding obligations of Vision 21, enforceable against it in
accordance with their respective terms.

                  (ii) The information provided by Vision 21 with respect to the
assumed liabilities contemplated by Section 1(f) to be set forth in the
assumption agreement to be delivered to the Practice at Closing will be true,
complete and correct in all material respects.

                  (iii) To Vision 21's knowledge, the financial information
delivered by Vision 21 to the Practice with respect to the Practice has been
true, complete and correct in all material respects.

         (b)      Representations and Warranties of the Practice and the
Shareholders. The Practice and the Shareholders jointly and severally hereby
represent and warrant that:

                                       7
<PAGE>   8
                  (i) The Practice is duly authorized to execute, deliver and
perform its obligations under this Agreement and any other agreement
contemplated hereby to be executed and delivered by the Practice, and to
consummate the transactions contemplated hereby, and this Agreement and each
other agreement contemplated hereby to be executed and delivered by the
Practice, are the legal, valid and binding obligations of the Practice and the
Shareholders, enforceable against each such party in accordance with their
respective terms.

                  (ii) Except as set forth on Schedule 4(b)(ii) hereto, (a)
there are no prepaid expenses, unbilled accounts receivable, unbilled services
or similar items relating to the Practice for the period beginning on the
Effective Date and ending on the date hereof, (b) neither the Shareholders nor
any individual acting at the direction of the Shareholders has deposited or
otherwise disposed of any revenue collected by or on behalf of the Practice for
the period beginning on the effective date of the BMA and ending on the
Effective Date other than in accordance with the BMA, (c) to the Shareholders'
knowledge, all ledger entries and other information provided by or on behalf of
the Practice to Vision 21 with respect to any revenue collected by or on behalf
of the Practice for the period beginning on the effective date of the BMA and
ending on the Effective Date, including receipts for Professional Eye Care
Services (as defined in the BMA), have been complete and accurate in all
material respects, and (d) to the Shareholders' knowledge, the financial
information delivered by the Practice to Vision 21 with respect to the Practice
has been true, complete and correct in all material respects.

                  (iii)    Except as set forth on Schedule 4(b)(iii) hereto,
neither the Practice nor the Shareholders have incurred any commitments,
obligations or liabilities on behalf of or in the name of the Practice for the
period beginning on the effective date of the BMA and ending on the Effective
Date.

                  (iv) The information provided by the Shareholders and the
Practice with respect to the assumed liabilities contemplated by Section 1(f) to
be set forth in the assumption agreement to be delivered to Vision 21 at Closing
will be true, complete and correct in all material respects.

         (c)      Representations and Warranties of LVCI. LVCI hereby represents
and warrants that:

                  (i) LVCI is duly authorized to execute, deliver and perform
its obligations under this Agreement and any other agreement contemplated hereby
to be executed and delivered by LVCI, and to consummate the transactions
contemplated hereby, and this Agreement and each other agreement contemplated
hereby to be executed and delivered by LVCI are the legal, valid and binding
obligations of LVCI, enforceable against it in accordance with their respective
terms.

         The Practice, the Shareholders and LVCI acknowledge that the approval
of the transactions contemplated herein by Vision 21's Board of Directors and
the banks which are a party to Vision 21's Credit Agreement, as amended (the
"Banks") will be in reliance upon the representations and warranties of the
Practice, the Shareholders and LVCI set forth herein.

                                       8
<PAGE>   9

         Section 5.        Confidentiality and Nondisparagement Covenants.

         (a)      Confidentiality Covenant. Except as needed to facilitate this
Agreement, no party shall, directly or indirectly, use for any purpose, or
disclose to any third party, any information of any other party (whether written
or oral), including any business, management or economic studies, patient lists,
proprietary forms, proprietary business or management methods, marketing data,
fee schedules, or trade secrets, including the terms and provisions of this
Agreement and any transaction or document executed by the parties pursuant to
this Agreement. Notwithstanding the foregoing, a party may disclose any
information that (a) is or becomes generally available to and known by the
public or the ophthalmic, optometric or optical community (other than as a
result of an unpermitted disclosure directly or indirectly by the disclosing
party or his or its affiliates, advisors, or representatives); (b) is or becomes
available to the disclosing party on a nonconfidential basis from a source other
than the disclosing party or his or its affiliates, advisors or representatives,
provided that such source is not and was not bound by a confidentiality
agreement with or other obligation of secrecy to the party to which the
confidential information relates or his or its affiliates, advisors or
representatives of which the disclosing party has knowledge; (c) has already
been or is hereafter independently acquired or developed by the disclosing party
without violating any confidentiality agreement with or other obligation of
secrecy to the party to which the confidential information relates or his or its
affiliates, advisors or representatives; or (d) the disclosing party is required
by law to disclose. Without limiting the other possible remedies to the party to
which the confidential information relates for the breach of this covenant, the
disclosing party agrees that injunctive or other equitable relief shall be
available to enforce this covenant, such relief to be without the necessity of
posting a bond, cash or otherwise.

         (b)      Nondisparagement Covenant. Each of the parties covenants and
agrees that they shall not at any time make or publish any negative, critical or
disparaging comments or statements, whether written or oral, about any of the
parties hereto, or their respective officers, directors or employees.

         Section 6.

         (a)      Covenant Not to Contract of Practice and Shareholders. The
Practice and the Shareholders covenant and agree that they shall not, and they
shall cause their employees, officers, directors, shareholders, affiliates and
representatives not to, directly or indirectly, through any partnership, joint
venture, affiliation or otherwise, solicit or contract with UCare Minnesota
("UCare"), or any affiliate of UCare, to administer UCare's vision benefit. The
Practice and the Shareholders further covenant and agree that they shall not,
directly or indirectly, influence UCare's decision to terminate its contract
with Vision 21's subsidiary, Block Vision, Inc., for a period of two years from
the Closing. Notwithstanding the foregoing, the Practice and the Shareholders
shall not be precluded (1) from entering into a contract to be a participating
provider in UCare's vision benefit products, and to give UCare access to the
Practice's network of optometric providers, or (2) from contracting with UCare
if UCare's contract with Block Vision, Inc. has terminated, provided that the
provisions of this Section 6(a) have not been breached prior to UCare's
termination of its contract with Block Vision, Inc.

                                       9
<PAGE>   10

         (b)      Covenant Not to Contract of Vision 21. Vision 21 covenants and
agrees that it shall not, and it shall cause its employees, officers, directors,
shareholders, affiliates and representatives not to, directly or indirectly
through any partnership, joint venture, affiliation or otherwise, solicit or
contract with BHCAG or any affiliate of BHCAG, to administer BHCAG's vision
benefit. Vision 21 further covenants and agrees that it shall not, directly or
indirectly, influence BHCAG's decision to terminate its contract with the
Practice for a period of two years from the Closing. Notwithstanding the
foregoing, Vision 21 shall not be precluded (1) from entering into a contract to
be a participating network in BHCAG's vision benefit products and to give BHCAG
access to Vision 21's network of optometric providers, or (2) from contracting
with BHCAG if BHCAG's contract with the Practice has terminated, provided that
the provisions of this Section 6(b) have not been breached prior to BHCAG's
termination of its contract with the Practice.

         Section 7.        Vision 21 Stock Options.

         (a)      Shareholders Stock Options. Except for those Stock Option
Agreements, if any, relating to a Shareholders' services as a consultant,
advisor or director of Vision 21, effective as of the Closing Date, all Stock
Option Agreements, if any, between Vision 21 and the Shareholders were deemed to
be terminated except that any stock options which were fully vested as of the
Effective Date were subject to exercise within ninety (90) days after the
Effective Date, in accordance with the terms of the applicable Stock Option
Agreement.

         (b)      Stock Options of Employees and Professionals. Effective as of
the last day of the Transition Period, all Stock Option Agreements, if any,
between Vision 21 and any Employees or any professional employees of the
Practice were terminated except that any stock options which were fully vested
as of the last day of the Transition Period, were subject to exercise within
ninety days after the last day of the Transition, in accordance with the terms
of the applicable Stock Option Agreement.

         Section 8.        Indemnification.

         (a)      Indemnification by Practice and Shareholders. The Practice and
the Shareholders, jointly and severally, shall defend, indemnify and hold Vision
21 and LVCI and their respective officers, directors, employees and agents
harmless and shall pay all losses, damages, fees, expenses or costs (including
reasonable attorney's fees) incurred by them based upon any claim arising out of
any breach by the Practice or the Shareholders of any of their obligations,
agreements, representations or warranties herein.

         (b)      Indemnification by Vision 21. Vision 21 shall defend,
indemnify and hold the Shareholders, the Practice and LVCI and their respective
officers, directors, employees and agents harmless and shall pay all losses,
damages, fees, expenses or costs (including reasonable attorney's fees)
incurred by them based upon any claim arising out of any breach by Vision 21 of
any of its obligations, agreements, representations or warranties herein.

         (c)      Indemnification by LVCI. LVCI shall defend, indemnify and
hold the Shareholders, the Practice and Vision 21 and their respective
officers, directors, employees and agents harmless and shall pay all losses,
damages, fees, expenses or costs (including reasonable

                                       10
<PAGE>   11

attorney's fees) incurred by them based upon any claim arising out of any breach
by Vision 21 of any of its obligations, agreements, representations or
warranties herein.

         Section 9.        Remedies. The parties agree that a material breach of
this Agreement by any party shall result in immediate and irreparable harm to
the other parties hereto. Accordingly, the parties agree that the non-defaulting
parties may seek and obtain injunctive or other equitable relief as against the
defaulting party hereunder, without posting bond or other security, in addition
to any other remedies available at law or in equity.

         Section 10.       Governing Law. This Agreement shall be governed by
the laws of the State of Minnesota without regard to such state's rules
concerning conflicts of laws. Any right to trial by jury with respect to any
claim or proceeding related to or arising out of this agreement is waived.

         Section 11.       Entire Agreement; Counterparts. This Agreement
reflects the entire agreement between the parties hereto with respect to the
subject matter hereof and no provision hereof may be modified or waived unless
such modification or waiver is in writing and is signed by both of the parties
hereto. This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute
one and the same agreement.

         Section 12.       Binding Effect. The provisions of this Agreement
shall be binding upon and inure to the benefit of the parties hereto.

         Section 13.       Confidentiality. Except as and to the extent required
by law, including, without limitation, any disclosures required under federal
and state securities and tax law, none of the parties hereto will, and each will
direct its officers, directors, employees, agents and representatives not to,
directly or indirectly, disclose or permit the disclosure of the terms of this
Agreement without the prior written permission of the other parties hereto.

         Section 14.       Attorneys' Fees. In the event of any litigation
arising out of or relating to this Agreement, the prevailing party shall be
entitled to recover all costs and reasonable attorneys' fees incurred,
including, but not limited to, costs and fees incurred in any investigations,
trials, bankruptcies and appeals.

         Section 15.       Expenses. Each of the parties shall be responsible
for and will pay its own expenses incurred in connection with the negotiation of
the transactions contemplated hereunder.

         Section 16.       DISCLAIMER OF WARRANTIES. THE ASSETS SHALL BE
TRANSFERRED TO THE PRACTICE AND THE SHAREHOLDERS, OR THEIR DESIGNEES, "AS IS,
WHERE IS" WITH NO WARRANTIES OR REPRESENTATIONS OTHER THAN TITLE AND OWNERSHIP.
VISION 21 DISCLAIMS ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, IN CONNECTION WITH
THE ASSETS, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF
MERCHANTIBILITY AND FITNESS FOR A PARTICULAR PURPOSE.

                                       11
<PAGE>   12

         Section 17.       Further Assurances. From and after the Closing, upon
the reasonable request of any party, the other party shall execute and deliver
such instruments, documents and other writings as may be reasonably necessary to
effectuate the intent and purpose of this Agreement.

         Section 18.       Full Access.

         (a)      Access by Vision 21. From and after the Closing, the Practice
and the Shareholders shall provide Vision 21 with access, upon prior reasonable
written request specifying the need therefor, during regular business hours, to
the books of account and records of the Practice to which Vision 21 has a
legitimate business need for the period from the date of the MEC Transaction
Agreement until the Effective Date, and Vision 21 and its representatives shall
have the right to make copies of such books and records.

         (b)      Access by the Practice and Shareholders. From and after the
Closing, Vision 21 shall provide the Practice and the Shareholders with access,
upon prior reasonable written request specifying the need therefor, during
regular business hours, to the books of account and records of Vision 21 to
which the Practice or the Shareholders have a legitimate business need for the
period from the date of the MEC Transaction Agreement until the Effective Date,
and the Practice and the Shareholders and its representatives shall have the
right to make copies of such books and records.

         Section 19.       Cooperation. Each of the parties hereto will
cooperate with the other parties in all respects, and each of the parties will
execute and deliver to the other parties hereto such other instruments and
documents and take such other actions as may be reasonably requested from time
to time by any other party hereto as necessary to carry out, evidence and
confirm the intended purposes of this Agreement. Such cooperation shall include,
without limitation, assistance to Vision 21 by the Shareholders and the Practice
as necessary in conjunction with any audits of Vision 21's financial statements,
including the timely completion of information requests or other inquiries as
required by Vision 21 or its auditors.

                                       12
<PAGE>   13

         IN WITNESS WHEREOF, the parties hereto have executed this Settlement
Agreement as of the date first above written.

VISION TWENTY-ONE, INC.                    MINNESOTA EYE CONSULTANTS, P.A.

BY: /s/ Bruce Maller                       BY: /s/ Richard L. Lindstrom, M.D.
   ------------------------------------       ----------------------------------
   Bruce Maller, Chairman of the Board        Richard L. Lindstrom, M.D.,
                                              its Managing Partner

                                           BY: /s/ Richard L. Lindstrom, M.D.
                                              ----------------------------------
LASER VISION CENTERS, INC.                    Richard L. Lindstrom, M.D.,
                                              individually

BY: /s/ Jim Wachtman                       BY: /s/ David Hardten, M.D.
   ------------------------------------       ----------------------------------
   Name: Jim Wachtman                         David Hardten, M.D., individually
   Title: President/C.O.O.

                                           BY: /s/ Thomas Samuelson, M.D.
                                              ----------------------------------
                                              Thomas Samuelson, M.D.,
                                              individually

                                       13
<PAGE>   14

                                 Schedule 1(e)
                                     Assets

1.       All furniture, fixtures and equipment used in the operation of the
         Practice;
2.       All inventory of supplies used in the operation of the Practice;
3.       All files, books and records used at the Practice;
4.       All telephone numbers used at the Practice;
5.       All leaseholds and leasehold improvements for the leased real property
         and all leaseholds for the leased equipment identified in the schedules
         of real property leases and equipment leases assumed by the Practice at
         Closing; and
6.       All trade names used by the Practice.
7.       Any Accounts Receivable (net of allowance for contractual adjustments)
         assigned by the Practice to Vision 21 under the BMA which are
         outstanding as of the Effective Date.
8.       All information systems and their respective databases, including the
         patient database relating to the Practice.

<PAGE>   15

                                 Schedule 1(h)
                               Practice Employees

See list of employees annexed hereto.

<PAGE>   16

                                 Schedule 1(j)
                           Lease Expense Reimbursement

None.

<PAGE>   17

                               Schedule 4(b)(ii)
     Prepaid Expenses; Unbilled Accounts Receivable; Unbilled Services; etc.
 .

None.

<PAGE>   18

                              Schedule 4(b)(iii)
                   Commitments; Obligations; Liabilities; etc.

None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00024-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00024-of-00352.parquet"}]]